This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

12 Bargain Stocks With Insider Support

Amyris

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Biofuel upstart Amyris (AMRS - Get Report) busted out of the IPO gate in late 2010, translating an opening day pricing in the mid-teens all the way up above $30 by early 2011. A year later, shares are down to $5, the company's production plans have been delayed, and the bank account needed to be replenished.

So the hefty insider buying you see above is simply insider purchases on a recent secondary offering. Shares have fallen another 10% since that secondary was completed.

>>7 Undeveralued IPO Stocks That Could Rebound in 2012

Still, this is a business with a great deal of promise. Amyris takes a basic organic material such as sugarcane and uses yeast and other microbes to convert it into industrial chemicals. Those end-product chemicals were typically made with either crude oil (which is currently quite expensive) or natural gas (which is currently quite cheap). So Amyris' success largely depends on what specific chemicals it will end up focusing upon to be economically viable.

After some recent setbacks, the company now thinks significant production volumes won't arrive before 2014, though the recent capital raise mitigates any cash burn concerns for now. These insiders are clearly in it for the long haul, and it may be a number of quarters before investors again flock to this promising business model.

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AMRS $2.02 0.50%
OPK $17.89 0.90%
TASR $31.41 0.35%
WEN $11.35 0.00%
AAPL $132.04 1.87%

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs